Medicinal chemistry is the discipline concerned with the design, synthesis, and optimization of biologically active compounds in drug discovery. Structure-activity relationship (SAR) analysis is the central tool for understanding how chemical structure influences biological activity and for guiding the optimization of lead compounds.

SAR begins with a lead compound identified through screening or rational design. Systematic modifications to the core scaffold, functional groups, and stereochemistry are made to probe the binding pocket and establish SAR trends. Classical SAR uses isosteric replacements where one functional group is replaced by another with similar size and electron distribution. Bioisosteres are substituents with similar physicochemical properties that produce comparable biological effects.

Lead optimization evaluates multiple parameters simultaneously. Potency is measured by IC50 or Ki values from in vitro assays. Selectivity against related targets reduces off-target toxicity. Ligand efficiency normalizes potency by molecular weight. Lipophilic efficiency combines potency with lipophilicity to assess drug-like quality. ADME properties including solubility, permeability, metabolic stability, and plasma protein binding are optimized through structural modifications.

The optimization process iterates through design, synthesis, testing, and analysis cycles. Computational tools including molecular docking, pharmacophore modeling, and free energy perturbation calculations guide structural modifications. Parallel synthesis and structure-based design accelerate the optimization timeline. The goal is a development candidate with appropriate potency, selectivity, pharmacokinetics, and safety for clinical evaluation.